Significantly increased risk of cancer in patients with diabetes mellitus: A systematic review and meta-analysis

Hiroshi Noto, Tetsuro Tsujimoto, Takehiko Sasazuki, Mitsuhiko Noda

Research output: Contribution to journalReview article

80 Citations (Scopus)

Abstract

Objective: To conduct a review and meta-analysis of the effect of diabetes mellitus on the incidence of and mortality attributable to cancer at any anatomic site.Methods: We performed a search of MEDLINE and the Cochrane Library for pertinent articles published from the origin of these databases to July 5, 2010, and included them in a qualitative review and meta-analysis of the risk of all-cancer incidence and mortality in patients with diabetes.Results: Among patients with diabetes (n = 257,222) in 12 cohort studies, the cancer incidence was about 7%. The cancer mortality was approximately 3% among patients with diabetes (n = 152,091) in 19 cohort studies. The pooled adjusted risk ratio (RR) of all-cancer incidence was significantly elevated-RR, 1.10 (95% confidence interval [CI], 1.04 to 1.17) overall; RR, 1.14 (CI, 1.06 to 1.23) for men; and RR, 1.18 (CI, 1.08 to 1.28) for women. Diabetes was also associated with an increased RR of mortality across all cancer types-RR, 1.16 (CI, 1.03 to 1.30) overall; RR, 1.10 (CI, 0.98 to 1.23) for men; and RR, 1.24 (CI, 1.11 to 1.40) for women.Conclusion: Cancer prevention and early detection by appropriate screening methods in patients with diabetes should be important components of clinical management and investigation, inasmuch as the exponentially increasing prevalence of diabetes will translate into substantial clinical and public health consequences on a global scale.

Original languageEnglish
Pages (from-to)616-628
Number of pages13
JournalEndocrine Practice
Volume17
Issue number4
DOIs
Publication statusPublished - Jul 1 2011

Fingerprint

Meta-Analysis
Diabetes Mellitus
Odds Ratio
Confidence Intervals
Neoplasms
Mortality
Incidence
Cohort Studies
Early Detection of Cancer
MEDLINE
Libraries
Public Health
Databases

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Significantly increased risk of cancer in patients with diabetes mellitus : A systematic review and meta-analysis. / Noto, Hiroshi; Tsujimoto, Tetsuro; Sasazuki, Takehiko; Noda, Mitsuhiko.

In: Endocrine Practice, Vol. 17, No. 4, 01.07.2011, p. 616-628.

Research output: Contribution to journalReview article

Noto, Hiroshi ; Tsujimoto, Tetsuro ; Sasazuki, Takehiko ; Noda, Mitsuhiko. / Significantly increased risk of cancer in patients with diabetes mellitus : A systematic review and meta-analysis. In: Endocrine Practice. 2011 ; Vol. 17, No. 4. pp. 616-628.
@article{fdb615b2ab5a45caa863f51433df555a,
title = "Significantly increased risk of cancer in patients with diabetes mellitus: A systematic review and meta-analysis",
abstract = "Objective: To conduct a review and meta-analysis of the effect of diabetes mellitus on the incidence of and mortality attributable to cancer at any anatomic site.Methods: We performed a search of MEDLINE and the Cochrane Library for pertinent articles published from the origin of these databases to July 5, 2010, and included them in a qualitative review and meta-analysis of the risk of all-cancer incidence and mortality in patients with diabetes.Results: Among patients with diabetes (n = 257,222) in 12 cohort studies, the cancer incidence was about 7{\%}. The cancer mortality was approximately 3{\%} among patients with diabetes (n = 152,091) in 19 cohort studies. The pooled adjusted risk ratio (RR) of all-cancer incidence was significantly elevated-RR, 1.10 (95{\%} confidence interval [CI], 1.04 to 1.17) overall; RR, 1.14 (CI, 1.06 to 1.23) for men; and RR, 1.18 (CI, 1.08 to 1.28) for women. Diabetes was also associated with an increased RR of mortality across all cancer types-RR, 1.16 (CI, 1.03 to 1.30) overall; RR, 1.10 (CI, 0.98 to 1.23) for men; and RR, 1.24 (CI, 1.11 to 1.40) for women.Conclusion: Cancer prevention and early detection by appropriate screening methods in patients with diabetes should be important components of clinical management and investigation, inasmuch as the exponentially increasing prevalence of diabetes will translate into substantial clinical and public health consequences on a global scale.",
author = "Hiroshi Noto and Tetsuro Tsujimoto and Takehiko Sasazuki and Mitsuhiko Noda",
year = "2011",
month = "7",
day = "1",
doi = "10.4158/EP10357.RA",
language = "English",
volume = "17",
pages = "616--628",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "4",

}

TY - JOUR

T1 - Significantly increased risk of cancer in patients with diabetes mellitus

T2 - A systematic review and meta-analysis

AU - Noto, Hiroshi

AU - Tsujimoto, Tetsuro

AU - Sasazuki, Takehiko

AU - Noda, Mitsuhiko

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Objective: To conduct a review and meta-analysis of the effect of diabetes mellitus on the incidence of and mortality attributable to cancer at any anatomic site.Methods: We performed a search of MEDLINE and the Cochrane Library for pertinent articles published from the origin of these databases to July 5, 2010, and included them in a qualitative review and meta-analysis of the risk of all-cancer incidence and mortality in patients with diabetes.Results: Among patients with diabetes (n = 257,222) in 12 cohort studies, the cancer incidence was about 7%. The cancer mortality was approximately 3% among patients with diabetes (n = 152,091) in 19 cohort studies. The pooled adjusted risk ratio (RR) of all-cancer incidence was significantly elevated-RR, 1.10 (95% confidence interval [CI], 1.04 to 1.17) overall; RR, 1.14 (CI, 1.06 to 1.23) for men; and RR, 1.18 (CI, 1.08 to 1.28) for women. Diabetes was also associated with an increased RR of mortality across all cancer types-RR, 1.16 (CI, 1.03 to 1.30) overall; RR, 1.10 (CI, 0.98 to 1.23) for men; and RR, 1.24 (CI, 1.11 to 1.40) for women.Conclusion: Cancer prevention and early detection by appropriate screening methods in patients with diabetes should be important components of clinical management and investigation, inasmuch as the exponentially increasing prevalence of diabetes will translate into substantial clinical and public health consequences on a global scale.

AB - Objective: To conduct a review and meta-analysis of the effect of diabetes mellitus on the incidence of and mortality attributable to cancer at any anatomic site.Methods: We performed a search of MEDLINE and the Cochrane Library for pertinent articles published from the origin of these databases to July 5, 2010, and included them in a qualitative review and meta-analysis of the risk of all-cancer incidence and mortality in patients with diabetes.Results: Among patients with diabetes (n = 257,222) in 12 cohort studies, the cancer incidence was about 7%. The cancer mortality was approximately 3% among patients with diabetes (n = 152,091) in 19 cohort studies. The pooled adjusted risk ratio (RR) of all-cancer incidence was significantly elevated-RR, 1.10 (95% confidence interval [CI], 1.04 to 1.17) overall; RR, 1.14 (CI, 1.06 to 1.23) for men; and RR, 1.18 (CI, 1.08 to 1.28) for women. Diabetes was also associated with an increased RR of mortality across all cancer types-RR, 1.16 (CI, 1.03 to 1.30) overall; RR, 1.10 (CI, 0.98 to 1.23) for men; and RR, 1.24 (CI, 1.11 to 1.40) for women.Conclusion: Cancer prevention and early detection by appropriate screening methods in patients with diabetes should be important components of clinical management and investigation, inasmuch as the exponentially increasing prevalence of diabetes will translate into substantial clinical and public health consequences on a global scale.

UR - http://www.scopus.com/inward/record.url?scp=84860390016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860390016&partnerID=8YFLogxK

U2 - 10.4158/EP10357.RA

DO - 10.4158/EP10357.RA

M3 - Review article

C2 - 21454235

AN - SCOPUS:84860390016

VL - 17

SP - 616

EP - 628

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 4

ER -